[Guide of recommendations for the diagnosis and neurorrehabilitative treatment of post-poliomielytic sequelar conditions].

Postpolio syndrome (PPS), which affects 20% to 50% of patients decades after initial poliovirus infection, poses a significant clinical challenge due to its unknown etiology and lack of pathogenic treatment. The main current theories point to degenerative processes secondary to the initial infection as the basis of its pathogenesis. Our guide addresses this complex landscape, providing a structured, evidence-based approach to the management of these sequelae. We emphasize the importance of: A personalized comprehensive evaluation; The development of multidisciplinary programs specifically designed to maximize functionality; Preventing complications and improving the quality of life of patients. We propose that these interventions be carried out under the supervision of an interdisciplinary team of specialists, who will use validated tools and personalized strategies based on the individual clinical characteristics of each patient. This approach ensures optimal functional benefit, aligned with current principles of evidence-based clinical practice.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-06-18
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[Guide of recommendations for the diagnosis and neurorrehabilitative treatment of post-poliomielytic sequelar conditions].

Fernando Velarde Rivera, M. Pérez, Ricardo Garcı́a, L. H. Ochoa Gutierrez et al.
PubMed
Genetic Neurodegenerative Diseases
article

[Guide of recommendations for the diagnosis and neurorrehabilitative treatment of post-poliomielytic sequelar conditions].

Fernando Velarde Rivera, M. Pérez, Ricardo Garcı́a, L. H. Ochoa Gutierrez, Joan Ferri Campos, Enrique Noé, Teresa Castro, Carolina Colomer Font, Alan Juárez Belaunde, Mónica Povedano Pandés
article en

Abstract

Postpolio syndrome (PPS), which affects 20% to 50% of patients decades after initial poliovirus infection, poses a significant clinical challenge due to its unknown etiology and lack of pathogenic treatment. The main current theories point to degenerative processes secondary to the initial infection as the basis of its pathogenesis. Our guide addresses this complex landscape, providing a structured, evidence-based approach to the management of these sequelae. We emphasize the importance of: A personalized comprehensive evaluation; The development of multidisciplinary programs specifically designed to maximize functionality; Preventing complications and improving the quality of life of patients. We propose that these interventions be carried out under the supervision of an interdisciplinary team of specialists, who will use validated tools and personalized strategies based on the individual clinical characteristics of each patient. This approach ensures optimal functional benefit, aligned with current principles of evidence-based clinical practice.

PubMedVol. 99
Ministerio de Transportes, Movilidad y Agenda Urbana (ES), Sociedad Española de Medicina Interna (ES), Sociedad Española de Nefrología (ES)
Openalex Percentile: Top 85%
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

[Guide of recommendations for the diagnosis and neurorrehabilitative treatment of post-poliomielytic sequelar conditions]. — Fernando Velarde Rivera, M. Pérez, et al. · PubMed (2025) | TGRS Research Map | TGRS